Get started
STAAR SURGICAL COSTAAR SURGICAL COSTAAR SURGICAL CO

STAAR SURGICAL CO

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast

SR3 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪2.19 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
149.80
Basic EPS (TTM)
0.29EUR
Net income (FY)
‪19.34 M‬EUR
Revenue (FY)
‪292.11 M‬EUR
Shares float
‪48.74 M‬
Beta (1Y)
0.66

About STAAR Surgical Company

Sector
Health Technology
Industry
Medical Specialties
CEO
Thomas G. Frinzi
Website
staar.com
Headquarters
Lake Forest
Employees (FY)
‪1.12 K‬
Founded
1982
FIGI
BBG000GMV7S3
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SR3 is 44.18 EUR — it has increased by 2.06% in the past 24 hours. Watch STAAR SURGICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange STAAR SURGICAL CO stocks are traded under the ticker SR3.
SR3 stock has risen by 17.84% compared to the previous week, the month change is a 17.41% rise, over the last year STAAR SURGICAL CO has showed a 6.58% decrease.
We've gathered analysts' opinions on STAAR SURGICAL CO future price: according to them, SR3 price has a max estimate of 56.12 EUR and a min estimate of 37.41 EUR. Watch SR3 chart and read a more detailed STAAR SURGICAL CO stock forecast: see what analysts think of STAAR SURGICAL CO and suggest that you do with its stocks.
SR3 reached its all-time high on Sep 8, 2021 with the price of 133.71 EUR, and its all-time low was 0.57 EUR and was reached on May 4, 2009. View more price dynamics on SR3 chart.
See other stocks reaching their highest and lowest prices.
SR3 stock is 3.04% volatile and has beta coefficient of 0.66. Track STAAR SURGICAL CO stock price on the chart and check out the list of the most volatile stocks — is STAAR SURGICAL CO there?
Today STAAR SURGICAL CO has the market capitalization of ‪2.19 B‬, it has decreased by 0.12% over the last week.
Yes, you can track STAAR SURGICAL CO financials in yearly and quarterly reports right on TradingView.
STAAR SURGICAL CO is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
SR3 earnings for the last quarter are 0.10 EUR per share, whereas the estimation was 0.06 EUR resulting in a 74.64% surprise. The estimated earnings for the next quarter are 0.22 EUR per share. See more details about STAAR SURGICAL CO earnings.
STAAR SURGICAL CO revenue for the last quarter amounts to ‪71.69 M‬ EUR, despite the estimated figure of ‪69.82 M‬ EUR. In the next quarter, revenue is expected to reach ‪88.92 M‬ EUR.
SR3 net income for the last quarter is ‪−3.09 M‬ EUR, while the quarter before that showed ‪7.03 M‬ EUR of net income which accounts for −144.04% change. Track more STAAR SURGICAL CO financial stats to get the full picture.
No, SR3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 30, 2024, the company has ‪1.12 K‬ employees. See our rating of the largest employees — is STAAR SURGICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAAR SURGICAL CO EBITDA is ‪26.40 M‬ EUR, and current EBITDA margin is 10.30%. See more stats in STAAR SURGICAL CO financial statements.
Like other stocks, SR3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAAR SURGICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAAR SURGICAL CO technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAAR SURGICAL CO stock shows the neutral signal. See more of STAAR SURGICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.